Drug intelligence / Profile preview

pinus taeda pollen extract

Development stage
Unknown
Lead developer
Greer Laboratories
Administration
Intradermal, Percutaneous, Subcutaneous, Sublingual
01

Overview

Pinus taeda pollen extract is a non-standardized allergenic extract derived from the pollen of the Loblolly Pine (*Pinus taeda*). Developed and manufactured by Greer Laboratories, it is primarily utilized as a diagnostic tool to identify allergic sensitivities in patients suspected of having pollen-related respiratory conditions. The extract is administered via percutaneous (scratch/prick) or intradermal testing, where it works by cross-linking allergen-specific IgE antibodies on the surface of mast cells and basophils in sensitized individuals. This interaction triggers the release of histamine and other mediators, resulting in a visible wheal-and-flare reaction. While primarily diagnostic, such extracts can also be used in subcutaneous immunotherapy (SCIT) to induce immunological tolerance.

Brand names
Loblolly Pine Pollen
Other names
Loblolly Pine Pollen ExtractPinus taeda pollen
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on pinus taeda pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pinus taeda pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call